StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health AFS Debt Securities — Amortized Cost by Quarter

AFS Debt Securities — Amortized Cost ($M)

QuarterlyAnnual

Cvs Health AFS Debt Securities — Amortized Cost: $29,564M in Q2 2026, up 10.9% from a year earlier. That is the highest of the 27 quarters on record here.

Latest, Q2 2026
29,564
Period ended Jun 30, 2026
Change on a year earlier
+10.9%
26,656 in Q2 2025
History
27 quarters
Since Q4 2018
Sources
4
Documents cited below

Where the Q2 2026 figure comes from

Source: CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Debt Securities — Amortized Cost ($M)Year on yearSource
Q2 2026Jun 30, 202629,564+10.9%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q1 2026Mar 31, 202628,593+8.5%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q4 2025Dec 31, 202528,600+7.7%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q3 2025Sep 30, 202527,705+4.8%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q2 2025Jun 30, 202526,656+8.6%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q1 2025Mar 31, 202526,345+13.0%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q4 2024Dec 31, 202426,562+19.2%CVS SEC 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q3 2024Sep 30, 202426,433+19.6%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q2 2024Jun 30, 202424,548+10.2%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q1 2024Mar 31, 202423,308+5.4%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q4 2023Dec 31, 202322,282+1.0%CVS SEC 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q3 2023Sep 30, 202322,101-0.6%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q2 2023Jun 30, 202322,267+0.3%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q1 2023Mar 31, 202322,114-3.0%CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q4 2022Dec 31, 202222,063-0.5%CVS SEC 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗
Q3 2022Sep 30, 202222,239–CVS SEC 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss) ↗

Cite this data

StockData. (2026). Cvs Health AFS Debt Securities — Amortized Cost ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/inv-afs-debt-cost

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.